| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |